New AI Paper Outlines FDA's Agency-Wide Approach to Protect Public Health and Promote Ethical Innovation

https://www.fda.gov/media/177030/download?utm_medium=email&utm_source=govdelivery FDA released “Artificial Intelligence and Medical Products: How CBER, CDER, CDRH, and OCP are Working Together.” This Paper outlines how FDA’s medical product centers are working together to protect public health while fostering responsible and ethical innovation through AI. The paper is a joint collaboration between FDA's Center for Biologics Evaluation and Research (CBER), Center for Drug Evaluation and Research (CDER), Center for Devices and Radiological Health (CDRH), and Office of Combination Products (OCP).